Cichocka-Jarosz E, Lis G, Pietrzyk J J
I Kliniki Chorób Dzieci, Polsko-Amerykańskiego Instytutu Pediatrii, Collegium Medicum, Uniwersytetu Jagiellońskiego w Krakowie.
Przegl Lek. 1997;54(9):614-9.
Pollen allergy constitutes about 1/3 of allergic disorders in people. Clinical manifestation of the disease depends on the natural allergen exposure. Main clinical symptoms are dealing with conjunctivitis, allergic rhinitis, bronchial asthma. Permanent increase in number of pollen sensitive patients observed during last years, depends on atopic genetic background, as well as natural allergen exposure and other environmental factors. Better understanding of pathophysiological mechanisms underlying the disease and opportunity to monitor the degree of allergen exposure seems to play the vital role in current treatment and prophylaxis. The allergic reaction takes place in two phases--the first one--early response (EAR) depends on IgE receptors binding which results in mast cell and basophils activation, in the second one--the late response (LAR), adhesive molecules, eosinophils, lymphocytes and their products, as well as neuropeptides are engaged. Also homeostasis of respiratory tract mucous membrane plays an important role at this stage.
花粉过敏约占人群过敏性疾病的三分之一。该疾病的临床表现取决于自然过敏原暴露情况。主要临床症状包括结膜炎、过敏性鼻炎、支气管哮喘。在过去几年中观察到花粉敏感患者数量持续增加,这取决于特应性遗传背景、自然过敏原暴露以及其他环境因素。更好地理解该疾病的病理生理机制以及监测过敏原暴露程度的机会,在当前的治疗和预防中似乎起着至关重要的作用。过敏反应分两个阶段发生——第一个阶段是早期反应(EAR),它依赖于IgE受体结合,导致肥大细胞和嗜碱性粒细胞活化;第二个阶段是晚期反应(LAR),涉及黏附分子、嗜酸性粒细胞、淋巴细胞及其产物以及神经肽。此外,呼吸道黏膜的稳态在这个阶段也起着重要作用。